TCI Wealth Advisors, Inc. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$3,546
-11.4%
39
-71.9%
0.00%
-100.0%
Q2 2022$4,000
-20.0%
1390.0%0.00%0.0%
Q1 2022$5,000
+25.0%
1390.0%0.00%0.0%
Q4 2021$4,000
-33.3%
139
+139.7%
0.00%0.0%
Q3 2021$6,000
+50.0%
58
+93.3%
0.00%0.0%
Q2 2021$4,000
+300.0%
30
+172.7%
0.00%
Q4 2020$1,000110.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders